Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL35AP35 (ribosomal protein L35a pseudogene 35) is a processed pseudogene located on chromosome 17q11.2. It is a non-protein-coding DNA sequence derived from the ribosomal protein L35a gene (RPL35A), which encodes a structural component of the 60S ribosomal subunit. Pseudogenes generally do not encode functional proteins, and while some can regulate parental gene expression by acting as competitive endogenous RNAs (ceRNAs) or by generating small interfering RNAs, no well-established functional or disease role has been described for RPL35AP35. It is not considered a therapeutic target, and there are no known drugs, biomarkers, or safety concerns associated with this pseudogene.
None — As a pseudogene, it is not a drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L35a pseudogene 35 (RPL35AP35).